Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Robert Alan Nagourney, Steven S. Evans, Peter Tran, Adam J. Nagourney, Paul H. Sugarbaker
Topics & Concepts
OxaliplatinFOLFOXMedicineFolinic acidColorectal cancerInternal medicineIrinotecanHyperthermic intraperitoneal chemotherapyChemotherapyOncologyGastroenterologyCapecitabineCancerSurgeryCytoreductive surgeryOvarian cancerIntraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentPancreatic and Hepatic Oncology Research